Women with stage III, IVA or IVB or recurrent endometrial cancer for a study adding an additional immunotherapy drug to the usual treatment lowers the chance of the cancer growing or spreading.
We are studying whether adding an immunotherapy drug to the usual treatment for endometrial cancer reduces the chance of the cancer growing or spreading. Some participants will be randomly assigned to receive the experimental immunotherapy drug and others will receive a placebo (looks like the study drug but contains no medication).
What we're hoping for
We hope that the experimental drug combination will lower the chance of endometrial cancer growing or spreading.
ClinicalTrials.gov Identifier: NCT03914612